|
Prior to joining Chemokine, Dr. Ely served as Vice President, Clinical and Medical Affairs at Biomira, Inc., where he supervised the global clinical development of the Company's lead cancer vaccines. As Vice President, Clinical and Medical Affairs at Lorus Therapeutics, Dr. Ely directed the global clinical development of anti-cancer drugs, including leading the Phase III planning of the lead immunotherapeutic compound for pancreatic cancer in Canada and the United States. While serving as Associate Medical Director at SmithKline Beecham Canada, Inc. (now, Glaxo Beecham), he directed all clinical research and development activities, including execution of approximately 50 international clinical trials in Canada. Prior senior posts also included Vice President, Clinical and Medical Affairs at Biochem Therapeutics, Inc., Director, Clinical Research at Abbott Laboratories Canada Inc., Medical Director at Asta Medica, France, Manager of Clinical Investigation and Medical Advisor for Ciba-Geigy Canada, Inc. | 